AnaptysBio
ANAB
#5384
Rank
โ‚น153.73 B
Marketcap
โ‚น5,192
Share price
6.90%
Change (1 day)
129.78%
Change (1 year)

Revenue for AnaptysBio (ANAB)

Revenue in 2026 (TTM): โ‚น20.79 Billion

According to AnaptysBio's latest financial reports the company's current revenue (TTM ) is โ‚น22.44 Billion. In 2025 the company made a revenue of โ‚น21.06 Billion an increase over the revenue in the year 2024 that were of โ‚น7.83 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AnaptysBio from 2015 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น20.79 B-1.26%
2025 โ‚น21.06 B168.95%
2024 โ‚น7.83 B448.25%
2023 โ‚น1.42 B67.79%
2022 โ‚น0.85 B-81.9%
2021 โ‚น4.70 B-14.27%
2020 โ‚น5.48 B861.47%
2019 โ‚น0.57 B63.18%
2018 โ‚น0.34 B-45.25%
2017 โ‚น0.63 B-43.68%
2016 โ‚น1.13 B-2.91%
2015 โ‚น1.16 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA